TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11572251

Group type: EXPERIMENTAL
Intervention: Rigid external distraction (13 patients)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Face mask protraction (2 patients)
Number of subjects: 15
Study: 9646600

Group type: EXPERIMENTAL
Intervention: Extended outpatient treatment of 180 days
Number of subjects: 230

Group type: COMPARATOR
Intervention: Regular outpatient treatment of 90 days
Number of subjects: 230
Study: 7523545

Group type: EXPERIMENTAL
Intervention: Enzymun-Test CYFRA 21-1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard material prepared from a cytoskeleton fraction of cultivated MCF-7 cells
Number of subjects: 0
Study: 31605667

Group type: EXPERIMENTAL
Intervention: Cooled Radiofrequency Ablation (CRFA)
Number of subjects: 33
Study: 28913600

Group type: EXPERIMENTAL
Intervention: coll‐HA scaffold
Number of subjects: 100

Group type: COMPARATOR
Intervention: BMS
Number of subjects: 100
Study: 27429936

Group type: EXPERIMENTAL
Intervention: Transoral approach (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transbuccal approach (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (Group B)
Number of subjects: 60
Study: 24494594

Group type: EXPERIMENTAL
Intervention: Conceptual instruction before problem solving
Number of subjects: 122

Group type: COMPARATOR
Intervention: Conceptual instruction after problem solving
Number of subjects: 122
Study: 22264615

Group type: EXPERIMENTAL
Intervention: PACU visit
Number of subjects: 45

Group type: COMPARATOR
Intervention: Usual care (no PACU visit)
Number of subjects: 45
Study: 20701567

Group type: EXPERIMENTAL
Intervention: Traditional Indigenous Games (TIG) delivered weekly for three months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 18785544

Group type: EXPERIMENTAL
Intervention: WG-LASIK in Group A (negative vertical coma)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: WG-LASIK in Group B (positive vertical coma)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Classic LASIK in control group of Group A
Number of subjects: 42

Group type: COMPARATOR
Intervention: Classic LASIK in control group of Group B
Number of subjects: 42
Study: 16382125

Group type: EXPERIMENTAL
Intervention: Topotecan alone
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Topotecan and cyclophosphamide
Number of subjects: 110

Group type: COMPARATOR
Intervention: Amifostine (randomly assigned group)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Overall therapy
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Isolated pulmonary metastases
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Widespread disease
Number of subjects: 110
Study: 14656033

Group type: EXPERIMENTAL
Intervention: Oral folic acid (5 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-methyltetrahydrofolate directly into the brachial artery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 10982541

Group type: EXPERIMENTAL
Intervention: DHA
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EPA
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 59
Study: 8633144

Group type: EXPERIMENTAL
Intervention: 2 mL/sec
Number of subjects: 45

Group type: COMPARATOR
Intervention: 3 mL/sec
Number of subjects: 45

Group type: COMPARATOR
Intervention: 4.5 mL/sec
Number of subjects: 45

Group type: COMPARATOR
Intervention: 6 mL/sec
Number of subjects: 45
Study: 1424880

Group type: EXPERIMENTAL
Intervention: Formoterol suspension aerosol (12 micrograms, twice daily)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Formoterol solution aerosol (12 micrograms, twice daily)
Number of subjects: 186
Study: 2933119

Group type: EXPERIMENTAL
Intervention: Tetracycline alone
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Oestrogen‐cyproterone acetate alone
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Combination of tetracycline and oestrogen‐cyproterone acetate
Number of subjects: 62
Study: 30729666

Group type: EXPERIMENTAL
Intervention: Serum Sema7A levels in AAS cases
Number of subjects: 210

Group type: COMPARATOR
Intervention: Serum Sema7A levels in controls
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Higher Sema7A levels
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Each 1-standard deviation increase in Sema7A
Number of subjects: 210
Study: 30527419

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no sodium bicarbonate therapy)
Number of subjects: 0
Study: 27043272

Group type: EXPERIMENTAL
Intervention: Gentle instruction
Number of subjects: 98

Group type: COMPARATOR
Intervention: Harsh instruction
Number of subjects: 98
Study: 24679222

Group type: EXPERIMENTAL
Intervention: Patellar resurfacing
Number of subjects: 2352

Group type: EXPERIMENTAL
Intervention: Metal-backed tibial components
Number of subjects: 2352

Group type: COMPARATOR
Intervention: Mobile bearings
Number of subjects: 2352
Study: 21198857

Group type: EXPERIMENTAL
Intervention: African American patients
Number of subjects: 3224

Group type: EXPERIMENTAL
Intervention: African American patients in those never completed high school
Number of subjects: 3224

Group type: EXPERIMENTAL
Intervention: African American patients who are high school graduates
Number of subjects: 3224

Group type: EXPERIMENTAL
Intervention: African American patients with partial college education
Number of subjects: 3224

Group type: EXPERIMENTAL
Intervention: African American patients who completed college education
Number of subjects: 3224

Group type: COMPARATOR
Intervention: White patients
Number of subjects: 3224
Study: 21141077

Group type: EXPERIMENTAL
Intervention: Long-acting carteolol hydrochloride 2% ophthalmic solution (LA), administered once a day
Number of subjects: 124

Group type: COMPARATOR
Intervention: Original carteolol hydrochloride 2% ophthalmic solution (CA), administered twice a day
Number of subjects: 124
Study: 17068328

Group type: EXPERIMENTAL
Intervention: 325 mg aspirin on alternate days
Number of subjects: 22040

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22040
Study: 16140593

Group type: COMPARATOR
Intervention: Topiramate (200-400 mg/day for adults or 5-9 mg/kg/day for children)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Topiramate
Number of subjects: 88
Study: 12145765

Group type: EXPERIMENTAL
Intervention: Fructose (75 g)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Glucose (75 g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle (300 mL water with noncaloric flavoring)
Number of subjects: 20
Study: 9469722

Group type: EXPERIMENTAL
Intervention: Cohort 1
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Cohort 2
Number of subjects: 71

Group type: COMPARATOR
Intervention: Both cohorts
Number of subjects: 71
Study: 7638685

Group type: EXPERIMENTAL
Intervention: Very-low-protein diet (0.4 g protein/kg/day supplemented with essential amino acids)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional low-protein diet (0.6 g protein/kg/day)
Number of subjects: 22
Study: 2203327

Group type: EXPERIMENTAL
Intervention: MK-212 (20 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 576879

Group type: EXPERIMENTAL
Intervention: Treatment A
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Treatment C
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Treatment B
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Treatment D
Number of subjects: 11

Group type: COMPARATOR
Intervention: All Treatments
Number of subjects: 11
Study: 31270297

Group type: EXPERIMENTAL
Intervention: APC combined with ESU
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: VATS
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Pleurodesis
Number of subjects: 70
Study: 27893491

Group type: EXPERIMENTAL
Intervention: TACE and low-molecular-weight heparins (LMWH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: TACE only
Number of subjects: 40
Study: 25722381

Group type: EXPERIMENTAL
Intervention: Trametinib (2 mg orally once daily)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 i.v. every 3 weeks)
Number of subjects: 129
Study: 23683456

Group type: EXPERIMENTAL
Intervention: Category group (CT) - listened to a tape containing five animal names
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Word recognition group (WM) - listened to a tape containing five intermediate-frequency words
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (CG) - listened to sea sounds
Number of subjects: 60
Study: 21235774

Group type: EXPERIMENTAL
Intervention: Mobile Cognitive Therapy (M-CT) in addition to treatment as usual (TAU)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 268
Study: 19586231

Group type: EXPERIMENTAL
Intervention: Day treatment, abstinence-contingent housing, and vocational training (various combinations)
Number of subjects: 543
Study: 17584549

Group type: EXPERIMENTAL
Intervention: High-bolus-dose tirofiban (25 microg/kg over 3 minutes, followed by 0.15 microg/kg per minute for 18 to 24 hours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abciximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 0
Study: 15685894

Group type: EXPERIMENTAL
Intervention: Automatic biopsy gun (Asecut)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Standard Tru-Cut needle
Number of subjects: 215
Study: 12237625

Group type: EXPERIMENTAL
Intervention: Thermal destruction of the endometrium
Number of subjects: 82

Group type: COMPARATOR
Intervention: Transcervical hysteroscopic endometrial resection
Number of subjects: 82

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 82
Study: 9845793

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound evaluation of hepatic veins and intra and extrahepatic portal vein territories in patients with APP.
Number of subjects: 13

Group type: COMPARATOR
Intervention: Doppler ultrasound evaluation of hepatic veins and intra and extrahepatic portal vein territories in healthy subjects (control group).
Number of subjects: 13
Study: 7865492

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 190

Group type: COMPARATOR
Intervention: Omeprazole
Number of subjects: 190

Group type: COMPARATOR
Intervention: Colloidal bismuth subcitrate (CBS)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: CBS and metronidazole double therapy
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: CBS, metronidazole and amoxicillin triple therapy
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: H. pylori eradicated group
Number of subjects: 190

Group type: COMPARATOR
Intervention: H. pylori not eradicated group
Number of subjects: 190
Study: 2764657

Group type: EXPERIMENTAL
Intervention: Cancer screening reminders
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Audit with feedback
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Patient education
Number of subjects: 62

Group type: COMPARATOR
Intervention: No intervention (controls)
Number of subjects: 62
Study: 81218

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy and cytoreductive surgery
Number of subjects: 0
Study: 30030134

Group type: EXPERIMENTAL
Intervention: Intervention (targeted combination intervention)
Number of subjects: 8231

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 8231
Study: 27354460

Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention
Number of subjects: 279

Group type: COMPARATOR
Intervention: Safety control
Number of subjects: 279
Study: 25024716

Group type: EXPERIMENTAL
Intervention: PF‐03654764 + fexofenadine
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine + fexofenadine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 22219060

Group type: EXPERIMENTAL
Intervention: Specific exercise program (9 exercises for lumbar region, executed daily for 8 minutes)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 98
Study: 20737584

Group type: EXPERIMENTAL
Intervention: Dipyridamole (0.56 mg/kg i.c.)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Verapamil (1 mg i.c.)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Dipyridamole after Verapamil
Number of subjects: 46

Group type: COMPARATOR
Intervention: Verapamil after Dipyridamole
Number of subjects: 46
Study: 18621929

Group type: EXPERIMENTAL
Intervention: Extracorporeal photopheresis (ECP) and standard therapy
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 95
Study: 16418557

Group type: EXPERIMENTAL
Intervention: Sex education program (4 sessions over 4 weeks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 41
Study: 13679675

Group type: EXPERIMENTAL
Intervention: Red wine (300 ml for two weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: White wine (300 ml for two weeks)
Number of subjects: 20
Study: 10377645

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) chip with scaling and root planing (SRP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 0
Study: 8777337

Group type: EXPERIMENTAL
Intervention: alpha interferon therapy for 4 months
Number of subjects: 3
Study: 1836220

Group type: EXPERIMENTAL
Intervention: Fosinopril 5 mg, increased to 10 mg if DBP > 95 mmHg, administered orally once daily for 4 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg, increased to 50 mg if DBP > 95 mmHg, administered orally once daily for 4 weeks
Number of subjects: 17
Study: 6316670

Group type: EXPERIMENTAL
Intervention: Cefotaxime treatment
Number of subjects: 153
Study: 31562930

Group type: EXPERIMENTAL
Intervention: I.V. House UltraDressing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 29303805

Group type: EXPERIMENTAL
Intervention: Division of short gastric vessels
Number of subjects: 102

Group type: COMPARATOR
Intervention: Nondivision of short gastric vessels
Number of subjects: 102
Study: 27422216

Group type: EXPERIMENTAL
Intervention: Spinal immobilization at 20° (group 2)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Spinal immobilization at 0° (group 1)
Number of subjects: 56
Study: 25341673

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide injection
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide injection (first injection)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide injection (second injection)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide injection (third injection)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Hyaluronic acid and NaCl injections
Number of subjects: 159
Study: 22870265

Group type: EXPERIMENTAL
Intervention: Ad35‐GRIN/ENV 2×10(9) (A)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ad35‐GRIN/ENV 2×10(10) (B)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ad35‐GRIN/ENV 2×10(11) (C)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ad35‐GRIN 1×10(10) (D)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ad35‐GRIN/ENV (A, B, C)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ad35‐GRIN (D)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ad35‐GRIN/ENV and Ad35‐GRIN
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 20220333

Group type: EXPERIMENTAL
Intervention: Tacrolimus plus prednisone
Number of subjects: 73

Group type: COMPARATOR
Intervention: Cyclophosphamide plus prednisone
Number of subjects: 73
Study: 18809799

Group type: EXPERIMENTAL
Intervention: Surgical treatment for PMR with coronary artery bypass graft
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Surgical treatment for PMR
Number of subjects: 54
Study: 16040637

Group type: EXPERIMENTAL
Intervention: CSE anaesthesia with EVE
Number of subjects: 60

Group type: COMPARATOR
Intervention: CSE anaesthesia without EVE (NEVE group)
Number of subjects: 60
Study: 12392825

Group type: EXPERIMENTAL
Intervention: Acetylcysteine (400 mg orally twice daily) and 0.45% saline intravenously
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo and 0.45% saline
Number of subjects: 121
Study: 10444731

Group type: EXPERIMENTAL
Intervention: Combined alpha fetoprotein testing and ultrasonography
Number of subjects: 9373

Group type: COMPARATOR
Intervention: Ultrasonography alone
Number of subjects: 9373

Group type: COMPARATOR
Intervention: Alpha fetoprotein test alone
Number of subjects: 9373
Study: 8697727

Group type: EXPERIMENTAL
Intervention: CD20dim T lymphocytes
Number of subjects: 41

Group type: COMPARATOR
Intervention: CD20bright B-cells
Number of subjects: 41
Study: 2179754

Group type: EXPERIMENTAL
Intervention: Ciclosporin (CS) 5‐8 mg/kg/24 h and warfarin
Number of subjects: 9

Group type: COMPARATOR
Intervention: Warfarin alone
Number of subjects: 9
Study: 7152084

Group type: EXPERIMENTAL
Intervention: Gastrils for the first 2 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Aludrox tablets for the first 2 weeks
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Gastrils
Number of subjects: 47

Group type: COMPARATOR
Intervention: Aludrox tablets
Number of subjects: 47
Study: 30975121

Group type: EXPERIMENTAL
Intervention: Active or passive smoking (defined as 1 cigarette or more per day for up to 1 year)
Number of subjects: 55806

Group type: EXPERIMENTAL
Intervention: Passive plus active smoking
Number of subjects: 55806

Group type: EXPERIMENTAL
Intervention: Combined smoking with the highest exposure dose
Number of subjects: 55806

Group type: EXPERIMENTAL
Intervention: All types of smoking exposure
Number of subjects: 55806
Study: 29171379

Group type: EXPERIMENTAL
Intervention: Collaborative care (n=249)
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Collaborative care (n=198)
Number of subjects: 485

Group type: COMPARATOR
Intervention: Usual care (n=236)
Number of subjects: 485

Group type: COMPARATOR
Intervention: Usual care (n=217)
Number of subjects: 485
Study: 26276749

Group type: EXPERIMENTAL
Intervention: Soy bread (SB)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Soy-almond bread (SAB)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Soy bread (SB) and Soy-almond bread (SAB)
Number of subjects: 32
Study: 23649573

Group type: EXPERIMENTAL
Intervention: 1-step self-etch adhesive (SEA)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 2-step self-etch adhesive (SEA)
Number of subjects: 48
Study: 21328434

Group type: EXPERIMENTAL
Intervention: DTI titration protocol (argatroban or bivalirudin)
Number of subjects: 130
Study: 19144734

Group type: EXPERIMENTAL
Intervention: Lupin kernel flour-enriched bread
Number of subjects: 88

Group type: COMPARATOR
Intervention: White bread (control)
Number of subjects: 88
Study: 20554370

Group type: EXPERIMENTAL
Intervention: aceclofenac 100mg-drotaverine 80 mg b.i.d
Number of subjects: 200

Group type: COMPARATOR
Intervention: aceclofenac 100mg alone b.i.d
Number of subjects: 200
Study: 16118805

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with autologous stem cell support (HDC)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Intermediate-dose chemotherapy (IDC)
Number of subjects: 246
Study: 11772910

Group type: EXPERIMENTAL
Intervention: 10 mg glyburide orally
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 10189518

Group type: EXPERIMENTAL
Intervention: 60 mg of nimodipine
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 90 mg of nimodipine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 5
Study: 7755126

Group type: EXPERIMENTAL
Intervention: Desipramine retreatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2182437

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy (including doxorubicin intensification with or without asparaginase)
Number of subjects: 553

Group type: COMPARATOR
Intervention: Less intensive chemotherapy
Number of subjects: 553
Study: 394274

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (Voltarol)
Number of subjects: 940
Study: 30204768

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 141

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 141

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 141
Study: 27424036

Group type: EXPERIMENTAL
Intervention: Prednisone 2.5-60 mg daily for 7 days
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 25528350

Group type: EXPERIMENTAL
Intervention: Non-sedation supplemented with pain management during mechanical ventilation
Number of subjects: 700

Group type: COMPARATOR
Intervention: Sedation with a daily wake-up trial
Number of subjects: 700
Study: 22500844

Group type: EXPERIMENTAL
Intervention: Metformin 1500 mg/day plus Calcium 1000 mg/day and Vitamin D 100000 IU/month for 6 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metformin 1500 mg/day
Number of subjects: 100
Study: 19937996

Group type: EXPERIMENTAL
Intervention: Shared-parameter models for incomplete longitudinal outcomes
Number of subjects: 0
Study: 18562162

Group type: EXPERIMENTAL
Intervention: HR-titrated beta-blocker dosing regimen
Number of subjects: 64

Group type: COMPARATOR
Intervention: Fixed-dose beta-blocker dosing regimen
Number of subjects: 64
Study: 16021543

Group type: COMPARATOR
Intervention: Conventional full spine radiographs
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Fluoroscopic scanning method
Number of subjects: 21
Study: 11949901

Group type: EXPERIMENTAL
Intervention: Familiarity principle in language learning
Number of subjects: 96
Study: 10369504

Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention, reducing fat intake to 20% of energy, with support from a nutritionist.
Number of subjects: 2208

Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention
Number of subjects: 2208

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 2208
Study: 7572830

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 150
Study: 2206816

Group type: EXPERIMENTAL
Intervention: Ethyl alcohol swab
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol swab
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-alcoholic cetrimide/chlorhexidine swab
Number of subjects: 20